Skip to main content
Figure 2 | Cardiovascular Diabetology

Figure 2

From: Effects of oral glucose-lowering drugs on long term outcomes in patients with diabetes mellitus following myocardial infarction not treated with emergent percutaneous coronary intervention - a retrospective nationwide cohort study

Figure 2

A: Risk of cardiovascular mortality and non-fatal myocardial infarction (MI), B: risk of cardiovascular mortality, and C: risk of all-cause mortality associated with glucose-lowering drug monotherapy. Time-dependent Cox analyses were performed with adjustments for age, sex, socioeconomic status, calendar year, concomitant medication and co-morbidity. Analyses for both individual sulfonylureas and sulfonylureas grouped as one pharmacological class were performed.

Back to article page